NewsRoom Articles - Page 244 of 596

WednesdayAug 04, 2021 4:20 am

420 with CNW — Cannabis Sales Continue to Increase as COVID-19 Restrictions Are Lifted

The sales gains recorded in the marijuana industry after business lockdowns following the 2020 pandemic seem to be long term, with executives noting that the pandemic may have produced a new group of consumers who are trying out or using cannabis to relieve stress among other reasons. Industry executives forecast that as the U.S. economy slowly reopens and people are allowed to begin taking trips and visiting restaurants and stores, consumers of marijuana will shift their purchases in favor of discreet consumption forms such as vape pens and edibles. A study that was conducted recently by the National Federation of…

TuesdayAug 03, 2021 4:20 pm

420 with CNW — Cory Booker Reveals Ongoing Talks to Gain Biden’s Support for Cannabis Legalization

Senator Cory Booker has revealed that he and his Senate colleagues are in talks with the White House regarding cannabis legalization. Now that Senate Majority Leader Chuck Schumer, Senate Finance Committee Chairman Ron Wyden and Booker have released a discussion draft of a federal marijuana legalization bill, they are working to bring President Joe Biden on board. President Biden has said that while he supports modest cannabis reform, including medical marijuana and expunging low-level cannabis offenses from people records, he opposes broad reform. The trio released the 163-page federal cannabis bill last month, asking the public for input so they…

TuesdayAug 03, 2021 9:30 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Is ‘One to Watch’

InMed has a world class leadership team with a successful track record of drug development and commercialization The company recently announced closing of a $12 million private placement InMed has a solid and expanding intellectual property portfolio with multiple patents filed The company recently signed an LOI to acquire rare cannabinoids manufacturer BayMedica InMed retains all commercial rights to its IntegraSyn manufacturing system InMed has filed clinical trial applications in several countries as part of a Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa The consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to…

TuesdayAug 03, 2021 9:00 am

Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Names New Executive, Retains PR Firm

CHALF appoints retail veteran Ginger Mollo as chief integration officer, Fifth & Root GM Mollo will oversee the positioning, expansion of the Fifth & Root Brand within the health and wellness beauty market as well as integration into Chalice brands Chalice has engaged MP-IMC to heighten profile of Fifth & Root in Chalice Brands product portfolio Chalice Brands (CSE: CHAL) (OTCQB: CHALF), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, has appointed retail veteran Ginger Mollo as chief integration officer for the company. In addition, Mollo will also serve as general manager of Fifth &…

TuesdayAug 03, 2021 4:20 am

420 with CNW — Study Finds That Marijuana Use Not Linked to Loss of Motivation

Recently published research shows that the use of cannabis is not independently linked to a loss of motivation among adolescents. The study was conducted over a two-year period by a team of researchers associated with the Florida International University. Study results were published in the Journal of the “International Neuropsychological Society.” The study’s authors note that a decrease in motivation is commonly mentioned as a consequence of marijuana. However, prior studies have largely centered on adults and have yielded different results. For their study, the researchers recruited more than 400 subjects aged between 14 and 17. Each subject had to…

MondayAug 02, 2021 4:20 pm

420 with CNW — Cannabis Boom in Michigan Creates Numerous Opportunities

Despite its youth and immaturity, America's state-legal cannabis industry has been dubbed one of the fastest-growing sectors in the country. The sector has generated billions of dollars in revenue for businesses and provided jobs for hundreds of thousands of people. In addition, projections have the space pulling in $43 billion by 2025. Cannabis is a high-risk industry and potentially a high-reward industry, especially for companies that can weather the risks, and many businesses are looking to throw their hats into the ring. Michigan, for instance, legalized recreational cannabis only one and a half years ago, and its large population coupled…

MondayAug 02, 2021 10:00 am

American Cannabis Partners Poised for Expansion, Seeks Growth Opportunities as Reliable Business Partner

ACP's strategy is based on leveraging opportunities in real estate and licensing in states that have recently passed legalization legislation Focused on complementary business segments — real estate, acquisition and development of proprietary assets, and ongoing cultivation operations, ACP appears poised for expansion Company seeks partnerships with companies with aligned personal, ethical, and business sensibilities to differentiate itself in assets, services, research, and philanthropy American Cannabis Partners (“ACP”) is a licensed, large-scale, and 100% organic cultivation company supplying multiple forms of raw product at consistent wholesale prices for manufacturing, distribution, and retail licenses. The company is considering additional growth via…

MondayAug 02, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Steadily Achieving Its Operational and Business Plan Objectives

Lexaria just completed dosing for its second human clinical study, HYPER-H21-2 The study sought to understand the human response to Lexaria’s DehydraTECH 2.0-enabled CBD The company also announced that its DehydraTECH-enabled consumer products are available for purchase in over 7,000 stores across the United States Lexaria also expanded its intellectual property portfolio with the allowance of its second patent in Japan It also received US$3,817,643 from warrant exercises, proceeds from which will be used to advance the company’s research and development program and for its general corporate purposes Lexaria Bioscience (NASDAQ: LEXX) has been making incredible strides in 2021 as…

MondayAug 02, 2021 4:20 am

420 with CNW — Senators, Feds Discuss Cannabis Legalization During Drug Overdose Hearing

Five decades after then President Richard Nixon declared drug abuse “public enemy number one,” paving the way for the era of the drug war, drug addiction and overdoses are still taking American lives. Since 1999, more than 800,000 people have died from drug overdoses in the United States, and drug abuse remains one of the country's most pressing issues. Now that most experts agree that the war on drugs has been an unmitigated failure, lawmakers have been pursuing other options to curb addiction and give existing addicts the help they need, rather than jail time. Last week, top federal health…

FridayJul 30, 2021 4:20 pm

420 with CNW – How Cannabis Cultivators Are Using Tech to Boost Productivity, Reduce Costs

Hemp and marijuana growers are using advanced technologies to increase quality and yields, cut down on labor costs, and decrease water as well as optimize energy use. These technologies, which also help make cultivation facilities more productive, include products to control pests that don’t use chemical pesticides, smartphone-controlled technology to raise and lower lighting and LED bulbs, systems that control a grow-room environment remotely, and sensors to fine-tune lighting and control irrigation. Some companies use sensors that enable cultivation operation managers to assess soil moisture using a software that can be viewed on a smartphone or computer. For instance, the…